Interleukin-6 in oral diseases: a review

被引：122
|
作者：
Nibali, L. [1 ,2 ]
Fedele, S. [2 ,3 ]
D'Aiuto, F. [1 ,2 ]
Donos, N. [1 ,2 ]
机构：
[1] UCL, Periodontol Unit, UCL Eastman Dent Inst, London WC1X 8LD, England
[2] UCL, Dept Clin Res, UCL Eastman Dent Inst, London WC1X 8LD, England
[3] UCL, Oral Med Unit, UCL Eastman Dent Inst, London WC1X 8LD, England
来源：
ORAL DISEASES | 2012年 / 18卷 / 03期
关键词：
interleukin-6; oral diseases; periodontitis; lichen planus; oral cancer; Sjogren's syndrome; TUMOR-NECROSIS-FACTOR; FUNCTIONAL GENE POLYMORPHISMS; GINGIVAL CREVICULAR FLUID; B-DEPENDENT CYTOKINES; RECEPTOR IL-6R GENE; HUMAN DENTAL-PULP; LICHEN-PLANUS; FACTOR-ALPHA; PERIODONTAL-DISEASE; TNF-ALPHA;
D O I：
10.1111/j.1601-0825.2011.01867.x
中图分类号：
R78 [口腔科学];
学科分类号：
1003 ;
摘要：
Interleukin-6 (IL-6) is a pleomorphic cytokine involved in a number of physiologic and pathologic processes including response to trauma and infection and development and progression of inflammation and malignancy. IL-6 is emerging as an important mediator and novel therapeutic target for chronic inflammatory diseases and cancer. The present study reviews the available evidence regarding the association between IL-6 and a range of oral diseases including infections (periodontal disease and endodontic infections), immunologically mediated disorders (oral lichen planus and Sjogren's syndrome) and malignancy (oral cancer and precancer). The role of common genetic variants of IL-6 in determining individual susceptibility to certain oral diseases, as well as novel therapeutic strategies based on IL-6 inhibition are also discussed. Oral Diseases (2012) 18, 236-243
引用
收藏
页码：236 / 243
页数：8
相关论文
共 50 条
  • [21] REGULATION OF INTERLEUKIN-6 AND INTERLEUKIN-6 RECEPTOR EXPRESSION
    BAUER, J
    GEROK, W
    BIOLOGICAL CHEMISTRY HOPPE-SEYLER, 1990, 371 (03): : 186 - 186
  • [22] Salivary interleukin-6 in the detection of oral cancer and precancer
    Panneer Selvam, Niranzena
    Sadaksharam, Jayachandran
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2015, 11 (03) : 236 - 241
  • [23] Interleukin-6 as a therapy target in oral squamous carcinoma
    Culig, Zoran
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2013, 17 (01) : 53 - 59
  • [24] The role of interleukin-6 and interleukin-6/interleukin-6 receptor-α complex in the pathogenesis of multiple myeloma
    Barillé, S
    Bataille, R
    Amiot, M
    EUROPEAN CYTOKINE NETWORK, 2000, 11 (04) : 546 - 551
  • [25] Interleukin-6
    Song, MC
    Kellum, JA
    CRITICAL CARE MEDICINE, 2005, 33 (12) : S463 - S465
  • [26] INTERLEUKIN-6
    LOTZ, M
    CANCER INVESTIGATION, 1993, 11 (06) : 732 - 742
  • [27] Interleukin-6 promoter haplotypes and interleukin-6 cytokine responses
    Rivera-Chavez, FA
    Peters-Hybki, DL
    Barber, RC
    O'Keefe, GE
    SHOCK, 2003, 20 (03): : 218 - 223
  • [28] Interleukin-6 and soluble interleukin-6 receptor in surgical trauma
    Sakamoto, K
    Ogawa, M
    Hisano, S
    Mita, S
    Ishiko, T
    SHOCK: FROM MOLECULAR AND CELLULAR LEVEL TO WHOLE BODY, 1996, 1102 : 161 - 166
  • [29] Interleukin-6, soluble interleukin-6 receptor/interleukin-6 complex and insulin resistance in obese children and adolescents
    G. De Filippo
    D. Rendina
    F. Moccia
    V. Rocco
    A. Campanozzi
    Journal of Endocrinological Investigation, 2015, 38 : 339 - 343
  • [30] POLYMORPHISMS OF THE INTERLEUKIN-6 RECEPTOR GENE AND PLASMA LEVELS OF INTERLEUKIN-6 AND SOLUBLE INTERLEUKIN-6 RECEPTOR IN SCHIZOPHRENIA
    Sasayama, Daimei
    Wakabayashi, Chisato
    Iijima, Yoshimi
    Fujii, Takashi
    Tatsumi, Masahiko
    Kunugi, Hiroshi
    SCHIZOPHRENIA BULLETIN, 2011, 37 : 77 - 77
12345